查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1988444

血管內視鏡設備市場：按產品類型、技術、應用和最終用戶分類 - 2026-2032年全球市場預測

Angioscope Device Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血管內內視鏡設備市場價值將達到 2.847 億美元，到 2026 年將成長至 3.0498 億美元，到 2032 年將達到 4.5051 億美元，複合年成長率為 6.77%。

主要市場統計數據
基準年 2025 2.847億美元
預計年份：2026年 3.0498億美元
預測年份 2032 4.5051億美元
複合年成長率 (%) 6.77%

簡要概述血管內內視鏡設備的臨床和操作引入：概述其手術價值、設備特性以及在醫療環境中採用的趨勢。

血管內視鏡設備正逐漸成為微創診斷和治療的關鍵工具，在多個臨床專科領域中兼顧可視化需求和手術效率。這些設備結合了光學技術、影像處理硬體和人體工學設計，使臨床醫生能夠更精準地進入血管和管腔解剖結構，進行可視化觀察和介入。隨著手術技術的進步和醫療服務向門診及社區醫療機構轉移，血管內視鏡因其縮短手術時間、提高診斷準確性和增強患者管​​理能力而日益受到重視。

技術進步、醫療轉型和相關人員的期望如何重塑血管內視鏡的設計、部署流程和採購重點。

血管內視鏡領域正經歷著一場變革，其驅動力來自於技術的進步、操作流程的改進以及相關人員期望的不斷變化。高解析度成像和光學技術的進步提高了診斷的可靠性，而小型化和改進的驅動系統則使得醫生能夠進入更遠端、更複雜的解剖結構，從而拓展了治療應用。這些技術進步也正在重塑採購標準，因為醫院和專科醫療中心需要能夠與更廣泛的影像和記錄基礎設施整合的互通性操作系統。

對於血管內視鏡領域的相關人員，近期美國關稅變化對採購經濟性、供應鏈策略和產品定位的實際影響。

美國近期關稅趨勢和貿易政策的變化，為醫療設備製造商和醫療保健系統的採購和供應計畫帶來了新的變數。關稅會增加進口零件和成品的整體成本，迫使製造商重新思考籌資策略、合約結構和定價模式。這些變化往往會加速關於區域供應多元化、關鍵零件國內採購以及本地組裝的討論，以減輕貿易中斷的影響。

將設備外形、臨床應用、終端用戶環境和成像技術與可操作的商業化方案連結起來的實用細分見解。

以細分市場主導導向的策略能夠最清楚地展現整個血管內視鏡市場中產品特性與臨床和商業性優先事項的觀點度。根據產品類型，市場可分為軟式和硬式兩種。軟式血管內視鏡又可細分為可重複使用型和一次性使用型，硬式血管內視鏡同樣可細分為可重複使用型和一次性使用型。這種二分法指南著關於生命週期規劃、再處理投入以及單次手術成本的討論，因此，製造商必須清晰闡述資本主導和耗材主導模式之間的權衡取捨。

制定區域策略，協調美洲、歐洲、中東和非洲以及亞太地區的監管環境、醫療服務提供者能力和商業模式。

區域趨勢影響整個血管內視鏡器械市場的採用率、監管應對路徑和市場進入策略。在美洲，大規模的集中和完善的門診手術基礎設施往往會加速臨床檢驗進程，並促進新技術的快速應用。然而，買家需要與臨床結果和營運效率相關的明確價值提案。在歐洲、中東和非洲，不同的管理體制和報銷方式要求進行個人化的證據生成，並採用靈活的商業模式，以適應各國特定的採購慣例和價格敏感度。

決定血管內視鏡生態系中成熟企業、專業光學公司和新興參與企業成功的競爭和策略差異化因素。

血管內視鏡器材領域的競爭動態由多家公司共同塑造，包括成熟的醫療設備製造商、專業的光學儀器製造商以及專注於數位化整合和一次性便捷性的新興技術公司。主要企業憑藉著深厚的臨床證據、涵蓋診斷和治療應用的廣泛產品系列，以及提供全面服務和培訓方案的能力脫穎而出，從而減少臨床實踐中的摩擦。此外，投資於模組化平台和配件生態系統的公司正在增加客戶的轉換成本，有助於提高客戶維繫。

為行業領導者提供切實可行的、高優先級的建議，以協調臨床證據、產品系列、供應彈性和經營模式，以實現永續成長。

尋求永續成長的行業領導者應優先考慮整合產品設計、臨床證據生成和客戶體驗的綜合方法。首先，投資於能夠產生可操作證據的臨床夥伴關係，以證明流程效率、診斷準確性和以患者為中心的療效，同時確保研究設計能夠反映採購委員會和報銷利益相關人員的需求。其次，透過平衡可重複使用產品和一次性產品，最佳化產品系列，以滿足醫院、門診中心和專科診所等不同終端用戶的偏好，同時簡化再處理和物流流程，以降低整體擁有成本。

透過結合設備架構分析、臨床文獻整合和相關人員訪談，我們透過高度透明的基於三角測量的調查方法，產生可操作的策略見解。

本研究採用三角測量法，結合設備架構分析、臨床文獻整合和相關人員訪談，深入洞察血管內視鏡市場趨勢。設備架構分析檢驗了光學系統、影像處理流程、影像重處理需求和配件生態系統，揭示了不同產品類別和技術之間的功能權衡。臨床文獻整合優先考慮同儕審查的手術結果、對比影像學研究和專業學會指南，以闡明診斷和治療效用。

綜合考慮技術、醫療保健服務、監管和商業性因素，得出決定血管內視鏡廣泛應用和長期價值實現的明確結論。

總之，血管內視鏡設備正處於光學技術創新、手術流程改善和醫療服務模式演變的策略性交會點。影像技術和設備人體工學的進步正在拓展其臨床應用範圍，而醫療服務模式的變革正在重塑人們對一次性產品和可重複使用產品的偏好。價格趨勢和供應鏈因素也為採購和定價策略增添了新的維度，這要求製造商和採購者都進行積極主動的規劃。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 血管內內視鏡設備市場：依產品類型分類

  • 靈活的
  • 硬度

第9章：血管內內視鏡設備市場：依技術分類

  • 高解析度
    • 4K
    • 全高清
  • 標準定義
    • SVGA
    • VGA

第10章 血管內內視鏡設備市場：依應用分類

  • 診斷
    • 消化器官系統
    • 呼吸系統
    • 泌尿系統
  • 治療
    • 循環系統
    • 消化器官系統
    • 呼吸系統

第11章 血管內內視鏡設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第12章 血管內內視鏡設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 血管內內視鏡設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 血管內內視鏡設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國：血管內內視鏡設備市場

第16章 中國：血管內視鏡器械市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems
  • Cardinal Health
  • Cook Medical
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Johnson & Johnson Services, Inc.
  • Karl Storz
  • LivaNova PLC
  • Medtronic PLC
  • Olympus Corporation
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Smith & Nephew PLC
  • Stryker Corporation
  • Terumo Corporation
  • Vena Medica
  • Zimmer Biomet
Product Code: MRR-6B0EA07975A0

The Angioscope Device Market was valued at USD 284.70 million in 2025 and is projected to grow to USD 304.98 million in 2026, with a CAGR of 6.77%, reaching USD 450.51 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 284.70 million
Estimated Year [2026] USD 304.98 million
Forecast Year [2032] USD 450.51 million
CAGR (%) 6.77%

A concise clinical and operational introduction to angioscope devices outlining procedural value, device characteristics, and adoption dynamics across care settings

Angioscope devices have emerged as pivotal tools in minimally invasive diagnostics and therapeutics, bridging visualization needs with procedural efficiency across multiple clinical specialties. These devices combine optics, imaging hardware, and ergonomics to enable clinicians to access, visualize, and intervene within vascular and luminal anatomy with improved precision. As procedural techniques evolve and care shifts toward outpatient and ambulatory settings, angioscopes are increasingly evaluated for their ability to reduce procedure time, improve diagnostic yield, and enhance patient throughput.

Clinicians and health system leaders assess these devices not only on imaging clarity and maneuverability but also on lifecycle considerations such as reprocessing workflows, single-use adoption, and integration with existing imaging stacks. Simultaneously, manufacturers navigate an environment shaped by regulatory scrutiny, reimbursement variability, and supply chain resilience. From a payer and provider perspective, the balance between upfront device cost and downstream clinical value is central to adoption decisions.

Transitioning from concept to routine use requires robust clinical evidence, seamless training pathways, and thoughtful deployment plans that reduce friction at the point of care. The introduction of higher-definition imaging options and modular device families is expanding clinical applicability while also demanding clear demonstration of incremental benefit to justify procurement and operational changes.

How technological advancement, care migration, and stakeholder expectations are reshaping angioscope design, adoption pathways, and procurement priorities

The angioscope landscape is undergoing transformative shifts driven by technological refinement, procedural migration, and evolving stakeholder expectations. High-definition imaging and advancements in optics are elevating diagnostic confidence, while miniaturization and improved drive systems enable access to more distal and tortuous anatomy, expanding therapeutic indications. These technological strides are also reshaping procurement criteria, as hospitals and specialty centers demand interoperable systems that align with broader imaging and documentation infrastructures.

Concurrently, care delivery is migrating toward ambulatory surgical centers and outpatient specialty clinics, prompting device manufacturers to prioritize portability, simplified sterilization workflows, and rapid turnover. This shift places renewed emphasis on single-use options where infection control, turnaround times, and predictable per-procedure economics are paramount. At the same time, reusable architectures are being redesigned for streamlined reprocessing and durable performance to retain relevance in high-volume hospital settings.

Stakeholder expectations are changing too: clinicians expect devices that reduce cognitive load and integrate seamlessly with digital health records, while hospital administrators require clear evidence of operational efficiency and cost-effectiveness. Regulatory trends toward higher evidentiary standards and reimbursement scrutiny are converging with supply chain resilience imperatives, making agility and clinical collaboration essential competitive differentiators.

Practical implications of recent United States tariff shifts on procurement economics, supply chain strategies, and product positioning for angioscope stakeholders

Recent tariff developments and trade policy shifts in the United States have introduced new variables into procurement and supply planning for medical device manufacturers and health systems. Tariffs can increase landed costs for imported components or finished devices, prompting manufacturers to reassess sourcing strategies, contract structures, and pricing models. These shifts often accelerate conversations about regional supply diversification, onshoring of critical components, and local assembly to mitigate exposure to trade disruptions.

Providers and group purchasing organizations may respond by tightening purchasing specifications, seeking alternative suppliers, or negotiating longer-term contracts to lock in pricing. This in turn impacts product roadmaps as manufacturers weigh the economics of producing multiple device configurations tailored to different regulatory and tariff regimes versus standardizing platforms to achieve scale. Additionally, increased costs related to tariffs can influence the relative attractiveness of single-use versus reusable devices, since per-procedure economics are sensitive to both component costs and downstream processing expenses.

From a strategic perspective, transparency in landed cost modeling, scenario planning, and proactive engagement with supply chain partners are essential. Manufacturers that communicate pricing drivers clearly and collaborate on inventory and logistics strategies will be better positioned to retain customer relationships while navigating the implications of tariff changes on product availability and procurement timelines.

Actionable segmentation insights linking device form factor, clinical application, end user environment, and imaging technology to practical commercialization choices

Segmentation-driven strategies provide the clearest lens for aligning product features with clinical and commercial priorities across the angioscope landscape. Based on product type, the market differentiates between flexible and rigid devices, with flexible angioscopes further categorized into reusable and single-use variants and rigid angioscopes likewise segmented into reusable and single-use options. This bifurcation informs lifecycle planning, reprocessing investments, and per-procedure cost discussions, making it essential for manufacturers to articulate the trade-offs between capital equipment and consumable-led models.

Based on application, device use is commonly divided between diagnostic and therapeutic categories, where diagnostic applications encompass gastrointestinal, respiratory, and urological use-cases and therapeutic applications span cardiovascular, gastrointestinal, and respiratory interventions. Devices designed for diagnostic work often prioritize high-fidelity visualization and ease of navigation, whereas therapeutic platforms emphasize working channel compatibility, instrument stability, and torque control for interventional maneuvers.

Based on end user, adoption patterns diverge across ambulatory surgical centers, hospitals, and specialty clinics, each of which presents distinct procurement cycles, procedural volumes, and service-level expectations. Finally, based on technology, angioscopes are differentiated between high definition and standard definition systems, where high definition further subdivides into 4K and Full HD offerings and standard definition breaks down into SVGA and VGA classes. These resolution tiers drive clinician perception of diagnostic value and influence integration requirements with existing imaging ecosystems.

Regional strategies that reconcile regulatory variability, provider capabilities, and commercial models across the Americas, Europe Middle East & Africa, and Asia Pacific landscapes

Regional dynamics shape adoption velocity, regulatory pathways, and go-to-market tactics across the angioscope device landscape. In the Americas, a concentration of large health systems and established ambulatory surgery infrastructures often accelerates clinical validation efforts and supports rapid deployment of new technologies, yet purchasers demand clear value propositions tied to clinical outcomes and operational efficiency. In Europe, Middle East & Africa, heterogeneous regulatory regimes and varying reimbursement approaches require tailored evidence generation and flexible commercial models that account for country-specific procurement norms and pricing sensitivities.

In the Asia-Pacific region, a diverse mix of mature markets and rapidly developing healthcare systems creates both scaling opportunities and complexity. Providers in high-growth markets may prioritize cost-effective single-use options to reduce capital barriers and reprocessing burdens, whereas centers of excellence in more developed economies may adopt premium high-definition systems to support advanced therapeutic programs. Across all regions, logistical considerations such as distribution networks, clinical training capacity, and after-sales service capabilities are decisive factors in successful deployments.

Therefore, regional strategies must blend clinical evidence, pricing models, and service architectures that reflect local regulatory expectations, reimbursement environments, and provider capabilities to ensure sustainable adoption and long-term utilization.

Competitive dynamics and strategic differentiators that define success for established firms, specialized optics companies, and emerging entrants in the angioscope ecosystem

Competitive dynamics in the angioscope device sector are shaped by a mix of established medical device firms, specialized optics companies, and emerging technology entrants that prioritize digital integration or single-use convenience. Leading players differentiate through depth of clinical evidence, breadth of product portfolios that span both diagnostic and therapeutic applications, and the ability to provide comprehensive service and training packages that reduce friction at the point of care. In addition, firms that invest in modular platforms and accessory ecosystems create switching costs that support customer retention.

Investment in higher-definition imaging, interoperability with hospital information systems, and partnerships with instrument OEMs are common strategies to expand addressable use cases. New entrants often pursue niche clinical segments or disruptive distribution models to gain footholds, while incumbents leverage scale advantages in manufacturing and regulatory experience to maintain market access. Across the competitive landscape, strategic alliances, licensing agreements, and targeted acquisitions frequently accelerate capability expansion and geographic reach.

Ultimately, companies that combine clinical collaboration, robust post-market surveillance, and transparent economic modeling are best positioned to build trust with providers and payers, enabling broader clinical adoption and deeper integration into procedural workflows.

Practical and prioritized recommendations for industry leaders to align clinical evidence, product portfolios, supply resilience, and commercial models for sustainable growth

Industry leaders seeking durable growth should prioritize an integrated approach that aligns product design, clinical evidence generation, and customer experience. First, invest in clinical partnerships that produce pragmatic evidence demonstrating procedural efficiency gains, diagnostic accuracy improvements, and patient-centered outcomes, while ensuring that study designs reflect the needs of purchasing committees and reimbursement stakeholders. Second, optimize product portfolios by balancing reusable and single-use offerings to meet diverse end-user preferences across hospitals, ambulatory centers, and specialty clinics, while streamlining reprocessing and logistics to reduce total cost of ownership.

Third, strengthen supply chain resilience through diversified sourcing, regional assembly options, and collaborative inventory management with key customers to mitigate exposure to trade policy volatility. Fourth, enhance commercial impact by developing interoperable systems that integrate with electronic health records and imaging archives, accompanied by scalable training programs and remote support capabilities that lower adoption barriers. Finally, adopt flexible pricing and contracting models that reflect regional reimbursement environments and provider procurement cycles, enabling pilots and phased rollouts that demonstrate value before larger commitments.

By operationalizing these priorities with cross-functional governance and measurable KPIs, industry leaders can convert innovation into sustained clinical and commercial outcomes.

A transparent triangulated methodology blending device architecture analysis, clinical literature synthesis, and stakeholder interviews to produce actionable strategic insights

This research applied a triangulated methodology combining device architecture analysis, clinical literature synthesis, and stakeholder interviews to generate robust insights on the angioscope landscape. Device architecture analysis examined optical systems, imaging pipelines, reprocessing requirements, and accessory ecosystems to map functional trade-offs across product classes and technologies. Clinical literature synthesis prioritized peer-reviewed procedural outcomes, comparative imaging studies, and guidance from specialty societies to contextualize diagnostic and therapeutic utility.

Stakeholder interviews included clinicians, procurement leaders, biomedical engineers, and distribution partners to surface real-world adoption barriers, training needs, and service expectations. These qualitative inputs were integrated with secondary sources to validate trends and to identify inflection points related to technology, reimbursement, and supply chain dynamics. Continuous validation loops were used to reconcile divergent perspectives and to ensure findings reflected practical, implementable strategies.

Where appropriate, sensitivity analyses and scenario planning were employed to explore the implications of cost, regulatory, and tariff variability on procurement and deployment decisions. The methodology emphasized transparency in assumptions and reproducibility of findings to support confident strategic decision-making.

A decisive conclusion synthesizing technology, care delivery, regulatory, and commercial drivers that will determine angioscope adoption and long term value realization

In conclusion, angioscope devices occupy a strategic intersection of optical innovation, procedural evolution, and shifting care delivery models. Technological improvements in imaging and device ergonomics are expanding clinical applicability, while changes in where care is delivered are reshaping product preferences for single-use and reusable formats. Tariff dynamics and supply chain considerations add another dimension that influences sourcing and pricing strategies, necessitating proactive planning by manufacturers and purchasers alike.

Segmentation clarity-across product type, application, end user, and technology tiers-enables more precise go-to-market alignment, while regional nuance demands tailored approaches to regulatory compliance, reimbursement engagement, and service deployment. Companies that combine rigorous clinical collaboration, resilient operations, and flexible commercial models will be best equipped to translate innovation into sustained clinical adoption and commercial success.

As the landscape continues to evolve, ongoing engagement with clinicians, payers, and procurement stakeholders will be essential to ensure that product development and deployment strategies remain relevant, evidence-driven, and value-focused.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Angioscope Device Market, by Product Type

  • 8.1. Flexible
  • 8.2. Rigid

9. Angioscope Device Market, by Technology

  • 9.1. High Definition
    • 9.1.1. 4K
    • 9.1.2. Full HD
  • 9.2. Standard Definition
    • 9.2.1. SVGA
    • 9.2.2. VGA

10. Angioscope Device Market, by Application

  • 10.1. Diagnostic
    • 10.1.1. Gastrointestinal
    • 10.1.2. Respiratory
    • 10.1.3. Urological
  • 10.2. Therapeutic
    • 10.2.1. Cardiovascular
    • 10.2.2. Gastrointestinal
    • 10.2.3. Respiratory

11. Angioscope Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Angioscope Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Angioscope Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Angioscope Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Angioscope Device Market

16. China Angioscope Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Becton, Dickinson and Company
  • 17.7. Boston Scientific Corporation
  • 17.8. Canon Medical Systems
  • 17.9. Cardinal Health
  • 17.10. Cook Medical
  • 17.11. Fujifilm Holdings Corporation
  • 17.12. GE Healthcare
  • 17.13. Hitachi Medical Corporation
  • 17.14. Johnson & Johnson Services, Inc.
  • 17.15. Karl Storz
  • 17.16. LivaNova PLC
  • 17.17. Medtronic PLC
  • 17.18. Olympus Corporation
  • 17.19. Philips Healthcare
  • 17.20. Shimadzu Corporation
  • 17.21. Siemens Healthineers
  • 17.22. Smith & Nephew PLC
  • 17.23. Stryker Corporation
  • 17.24. Terumo Corporation
  • 17.25. Vena Medica
  • 17.26. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANGIOSCOPE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANGIOSCOPE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY 4K, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY 4K, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY 4K, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FULL HD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FULL HD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FULL HD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SVGA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SVGA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SVGA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY VGA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY VGA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY VGA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 154. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)